Position in GRFS
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$92,614
-$15,359 QoQ
Shares Held
11,548
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Manske Wealth Management holds $11,013,103 across 10 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
15,455 | $1,985,967 | |
| 2 | GSK |
GSK plc
|
37,767 | $1,979,746 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
23,392 | $1,347,847 | |
| 4 | PFE |
Pfizer Inc
|
53,019 | $1,276,697 | |
| 5 | NVO |
Novo Nordisk A S
|
24,546 | $1,176,735 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
8,591 | $1,085,386 | |
| 7 | LLY |
ELI LILLY & Co
|
549 | $658,487 | |
| 8 | JNJ |
Johnson & Johnson
|
2,186 | $555,178 |
All Filings in GRFS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $92,614 | 11,548 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $107,973 | 11,548 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $150,894 | 15,150 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $153,228 | 16,950 | Shares | Sole | 2025-11-12 | |
| 2025-03-31 | $120,514 | 16,950 | Shares | Sole | 2025-11-12 | |
| 2024-12-31 | $175,212 | 23,550 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||